Camille Sebaaly
2021
In 2021, Camille Sebaaly earned a total compensation of $346K as Chief Financial Officer at Sunshine Biopharma.
Compensation breakdown
| Salary | $40,000 |
|---|---|
| Stock Awards | $306,000 |
| Total | $346,000 |
Sebaaly received $306K in stock awards, accounting for 88% of the total pay in 2021.
Sebaaly also received $40K in salary.
Rankings
In 2021, Camille Sebaaly's compensation ranked 11,419th out of 12,406 executives tracked by ExecPay. In other words, Sebaaly earned more than 8.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,419 out of 12,406 | 8th |
Division Manufacturing | 5,023 out of 5,492 | 9th |
Major group Chemicals And Allied Products | 2,227 out of 2,368 | 6th |
Industry group Drugs | 1,977 out of 2,089 | 5th |
Industry Pharmaceutical Preparations | 1,458 out of 1,536 | 5th |
Source: SEC filing on October 18, 2023.
Sebaaly's colleagues
We found two more compensation records of executives who worked with Camille Sebaaly at Sunshine Biopharma in 2021.